Back to Search Start Over

1333TiPCAPTEM or FOLFIRI as second-line therapy in neuroendocrine carcinomas and exploratory analysis of predictive role of PET imaging and biological markers (SENECA study).

Authors :
Bongiovanni, A
Pusceddu, S
Leo, S
meglio, G Di
Gelsomino, F
Pucci, F
Berardi, R
Ricci, S
Lolli, I
Bergamo, F
Source :
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Publication Year :
2018

Subjects

Subjects :
*BIOMARKERS
*NUCLEAR medicine
*ONCOLOGIC surgery
*CARCINOMA

Details

Language :
English
ISSN :
09237534
Volume :
29
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
133285597
Full Text :
https://doi.org/10.1093/annonc/mdy293.026
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details